The Technical Analyst
Manhattan Scientifics, [MHTX]
Exchange: PNK Industry: Medical Devices
Manhattan Scientifics, Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0020
America/New_York / 3 mai 2024 @ 15:25
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 1.119 mill |
| EPS: | -0.0100 |
| P/E: | -0.200 |
| Earnings Date: | May 06, 2024 |
| SharesOutstanding: | 559.28 mill |
| Avg Daily Volume: | 0.123 mill |
| RATING 2024-05-03 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | |||
| Gr.Profit | n/a | n/a | ||||
| Ebit | n/a | |||||
| Asset | n/a | |||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.200 | sector: PE -11.58 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.200 | industry: PE -6.92 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.0000 (-99.37%) $-0.0020 |
| Date: 2024-05-04 |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0010 - 0.0030 ( +/- 50.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2016-06-30 | Theoharis Chris | Buy | 500 000 | Stock Options |
| 2015-06-30 | Theoharis Chris | Buy | 500 000 | Stock Options |
| 2016-06-30 | Schatz Larry H | Buy | 500 000 | Stock Options |
| 2015-06-30 | Schatz Larry H | Buy | 500 000 | Stock Options |
| 2016-06-30 | Friedman Leonard | Buy | 500 000 | Stock Options |
| INSIDER POWER |
|---|
| 0.00 |
| Last 96 transactions |
| Buy: 57 428 706 | Sell: 47 487 127 |
Forecast:
16:00 - $0.0020
Live Trading Signals (every 1 min)
Forecast
1: 15:35 - $0.0020
Forecast 2: 16:00 - $0.0020
Forecast 3: 16:00 - $0.0020
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0020 (0.00% ) |
| Volume | 7.22 mill |
| Avg. Vol. | 0.123 mill |
| % of Avg. Vol | 5 863.23 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For MHTX
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
MHTX
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Latest Press Releases
2017-06-14 15:59:00 - Press Release
Manhattan Scientifics Schedules Investor Conference Call On Its
Affiliate, Imagion Biosystems Ipo
New york--(business wire)--manhattan scientifics inc. (otcqb: mhtx) announced today that it will host a conference call for mhtx investors at 12:00 pm eastern time on friday, june 16, 2017 to provide an update and briefing on the pending imagion biosystems ipo (ibx). there will not be a q&a session and participants will be restricted to listening mode. participants can dial into the call using the following instruction. usa & canada: conference toll free number: 1-800-753-0565 conference toll number: 1-512-879-2025 participant access code: 673031# participant code command: *0 – to summon an operator a replay of the call will be posted on the company website http://mhtx.com. manhattan scientific’s affiliate company, imagion biosystems limited, formerly known as senior scientific, llc, has filed a prospectus with the australian securities and investment commission and has applied to the australian securities exchange for an initial public offering ("ipo") to raise up to a$12 million at a$0...